Dilip J. Mehta M.D. Ph.D. is Director at Targanta Therapeutics Corp. (TARG). They have made 1 open-market trade across 1 company since 2010, most recently 2010-07-06.
CIK 0001225494
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $37K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SPPI | BUY | 2010-07-06 | 2010-07-06 | $3.74 | $37K | -18.2% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.